AcelRx Pharmaceuticals logo

AcelRx Pharmaceuticals ACRX

$ 0.86 7.5%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Country

usaUSA

IPO year

2011

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. Vincent Angotti

Employees in the company

99

Shares

14.3 M

Market Cap[1]

$ 6.35 M

EBITDA (LTM)

$ -27.6 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.